|Last Price$290.54||Day Change (%)0.05%|
|Open Price$290.52||Day Change ($)0.15|
|Day Range288.85–291.17||52-Week Range240.30–303.74|
As of Mon 5/22/2017 4:05:00 PM | USD
Exact Sciences CEO and short-seller go mano-a-mano on CNBC, stock pares losses
Capricor's stock tumbles toward record low after disappointing trial results
Ziopharm Oncology's stock tumbles after stock offering prices at deep discount
How to make money as the 'disenchanted' middle class changes politics
Hagens Berman Notifies BlackRock ETF Investors of Court Ruling Upholding August 24, 2015 ETF Flash Crash Case and Scheduling Hearing
UPDATE: Bill Gates tells new grads to read this book that says the world is getting better
Bill Gates tells new grads to read this book that says the world is getting better
Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.
As the sector has continued to best the broader market, a look both at the dynamics that would drive further outperformance by the sector and at funds that investors can use to tap those themes.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...